Eckert & Ziegler SE (FRA:EUZ)

Market Cap	899.19M
Revenue (ttm)	304.47M
Net Income (ttm)	39.75M
Shares Out	n/a
EPS (ttm)	0.63
PE Ratio	22.62
Forward PE	18.20
Dividend	0.17 (1.14%)
Ex-Dividend Date	Jun 19, 2025

Volume	75
Average Volume	203
Open	14.37
Previous Close	14.64
Day's Range	14.34 - 14.37
52-Week Range	14.33 - 23.00
Beta	n/a
RSI	30.85
Earnings Date	Mar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co...

• Industry: Industrial Inorganic Chemicals
• Founded: 1992
• Employees: 1,085
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.